Memory Training for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a memory training program called CogMed can help people with mild memory issues improve their memory and reduce stress. Researchers are also examining whether this program affects a blood marker linked to Alzheimer's disease. Participants will either continue their regular treatment or use CogMed for 25 minutes a day, five days a week, for ten weeks. This trial suits those with mild cognitive impairment who have internet access and can see and hear well enough to follow study procedures. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could enhance memory care strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this memory training program is safe?
Previous studies have not shown any safety concerns with CogMed Working Memory Training. Research indicates that participants find this memory training program easy to handle. Users perform memory exercises on a computer, with sessions typically lasting 20 to 25 minutes and occurring several times a week. To date, no harmful effects have been reported from this type of training, suggesting it is a safe option for those seeking to improve their memory.12345
Why are researchers excited about this trial?
Researchers are excited about the CogMed intervention for mild cognitive impairment because it focuses on enhancing working memory through a computerized training program. Unlike traditional treatments that might rely on medication, CogMed offers a non-pharmacological approach by engaging participants in regular, structured cognitive exercises. This method empowers individuals to take an active role in their cognitive health, potentially leading to improvements in memory function without the side effects associated with drugs. Plus, the accessibility of a digital platform allows for consistent training in the comfort of one’s home, making it a convenient option for many.
What evidence suggests that CogMed is effective for improving memory in people with mild cognitive impairment?
Research has shown that CogMed, a computer-based memory training program, can improve short-term memory skills, such as remembering words and visual information. Some studies have found these improvements in adults with early memory issues. In this trial, participants in the Intervention Group will receive the CogMed intervention. While the benefits may last for a while, they tend to diminish over time. CogMed aims not only to enhance memory but also to reduce stress. Early findings suggest it might influence levels of p-Tau 217, a marker linked to Alzheimer's disease. Although more research is needed, these initial results are encouraging for people with mild memory problems.13567
Who Is on the Research Team?
Yonas E Geda, M.D, MSc
Principal Investigator
Barrow Neurological Institute, Alzheimer's Disease and Cognitive Disorders Division
Are You a Good Fit for This Trial?
This trial is for people over 50 with mild memory problems who can use the internet and understand English (or have a translator). They should be able to see and hear well enough for study tasks. Those with moderate or severe dementia, or an MMSE score below 19, cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the intervention group undergo CogMed intervention for 25 minutes daily, 5 days a week for 10 weeks, while the control group follows Treatment As Usual (TAU).
Follow-up
Participants are monitored for changes in working memory, stress, and other cognitive measures at a 3-month follow-up after the intervention period.
What Are the Treatments Tested in This Trial?
Interventions
- CogMed
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Joseph's Hospital and Medical Center, Phoenix
Lead Sponsor
Barrow Neurological Foundation
Collaborator
Barrow Neurological Institute
Collaborator